Impact Of Muscle Vibration On Gait Control

  • days left to enroll
  • participants needed
  • sponsor
    M.D. Anderson Cancer Center
Updated on 13 October 2021


This is a single-site interventional open label pilot study of a non-significant risk medical device on patients with defined peripheral neuropathy secondary to chemotherapy (N=10). Patients who have received chemotherapy and have evidence of neuropathy will be seen at MD Anderson. Their severity of neuropathy will be documented and assessed by physical therapy, occupational therapy and based on self-reported activities of daily living (ADL) impairment.


Primary Objective:

To assess the effect of a vibrating device applied to selected muscles on the step

Secondary Objectives:

  • To summarize the adverse events of different levels from using the vibrator device in oncologic AYA patients visiting the outpatient clinic.
  • To summarize the irritation, pain, and sensation of the application of vibration by the AYA patients, as determined by the survey during the application

Condition Muscle
Treatment Vibrating Device
Clinical Study IdentifierNCT05061238
SponsorM.D. Anderson Cancer Center
Last Modified on13 October 2021


Yes No Not Sure

Inclusion Criteria

Subjects between the ages of 15 and 39 years
Study subjects, or their parent/legal guardian for subjects <18 years, must be able to understand the purpose and risks of the study and to provide signed and dated informed consent and authorization to use confidential health information in accordance with national and local subject privacy regulations
History of any type of cancer
Diagnosed with peripheral neuropathy-associated gait dysfunction as defined by the treating physician
Able (in the Investigators estimation) and willing to comply with all study requirements
Subjects must be able to walk without the assistance of a walker or similar support apparatus
Patients with ankle foot orthosis (AFOs) are allowed but will need to be removed prior to testing

Exclusion Criteria

Participants with amputations, prosthetics, congenital malformations or any severe lower extremity deformities affecting gait before trials
Abnormalities of the lower extremities as determined by the investigator
Unstable participants or participants with hypotension (systolic blood pressure <90 and diastolic blood pressure < 60mmHg)
Any other significant disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study
Other unspecified reasons that, in the opinion of the Investigator make the subject unsuitable for enrolment
Pregnant women
Children <15 years old
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note